Monday, April 15, 2024
Monday, April 15, 2024
Monday, April 15, 2024

Purdue, Maker of OxyContin, Pleads Guilty to Federal Criminal Charges

»

Published

»

Friendly Notice

Your Content, a digital media platform owned by Original Media Group Corporation, is an educational not-for-profit organization headquartered in Pennsylvania. The publication is run by a team of artists and journalists who create and publish content on a range of topics, including news, politics, lifestyle, and entertainment.

Recently, AtNight Media LLC (d/b/a AtNight Media Group) has expressed an interest in acquiring the publication. As part of the acquisition review process, Your Content's operations have been temporarily halted. The audit will involve a thorough evaluation of the publication's financial, legal, and operational aspects. This will ensure that the acquisition is in line with the best interests of all parties involved.

The temporary halt of operations means that Your Content's website and social media accounts will not be updated until further notice. However, the team at Your Content remains committed to delivering high-quality content to its readers and viewers. The publication will resume its operations as soon as the acquisition review is complete.

We apologize for any inconvenience caused and thank you for your understanding.

Sign up with Your Content for the latest updates. Have a story or news tip? Contact our 24/7 newsroom at 833.336.8013 or email us.

OxyContin maker Purdue Pharma has pleaded guilty to federal criminal charges, formally admitting role in opioid crisis, Your Content has learned.

Purdue Pharma pleaded guilty Tuesday to three criminal charges, formally admitting its role in an opioid epidemic that has contributed to hundreds of thousands of deaths over the past two decades, according to the Associated Press.

In a virtual hearing with a federal judge in Newark, New Jersey, the OxyContin maker admitted impeding the U.S. Drug Enforcement Administration’s efforts to combat the addiction crisis, reports Bloomberg. Purdue acknowledged that it had not maintained an effective program to prevent prescription drugs from being diverted to the black market, even though it had told the DEA it did have such a program, and that it provided misleading information to the agency as a way to boost company manufacturing quotas.

Your Content is a publication centered around breaking news, trends, and true crime investigations. Sign up to receive our biggest stories as soon as they’re published.

Ohio High School Principal Resigns Amid Sexual Harassment Investigation

Robert Griffiths, the principal of an Ohio high school, has resigned following allegations of...

Serial Bank Robber Arrested in Metro Atlanta Following Multi-Agency Investigation

Dallas, Georgia, police, in conjunction with other law enforcement agencies, have successfully apprehended a...

Search for Armed Robbery Suspect in Maumelle Dollar General

The Pulaski County Sheriff’s Office is requesting public help in identifying a suspect involved...

Birmingham Police Arrest Man as Investigation into Father’s Disappearance Takes a Dark Turn

BIRMINGHAM, Ala. — The Birmingham Police Department has reported a significant development in a...